Turkish Validity and Reliability of Short-Western Ontario Rotator Cuff Disability Index
Launched by ISTANBUL MEDENIYET UNIVERSITY · Oct 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on adapting a questionnaire called the Short-Western Ontario Rotator Cuff Disability Index (SHORTWORC) for Turkish-speaking patients. This questionnaire is designed to assess how rotator cuff injuries affect a person's quality of life and shoulder function. The study aims to ensure that the SHORTWORC is both valid (accurately measures what it’s supposed to) and reliable (produces consistent results over time) when used by Turkish-speaking patients. To do this, the researchers will ask 35 participants with rotator cuff injuries to complete the questionnaire during their rehabilitation sessions, along with other established assessments, to compare results.
To be eligible for the study, participants must be over 18 years old, diagnosed with a rotator cuff injury, and able to communicate in Turkish. They should also experience some pain related to their injury. However, individuals with other shoulder problems, those who cannot read or write in Turkish, or those who have had shoulder surgeries or fractures will not be included. If you are eligible and choose to participate, you can expect to fill out some questionnaires about your shoulder condition during your rehabilitation sessions, which will help improve care for future patients with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals over 18 years of age who have been diagnosed with a rotator cuff injury,
- • Patients whose native language is Turkish,
- • Individuals with pain intensity \> 2 according to the Visual Analog Scale,
- • Individuals with a Mini Mental State Examination score of \>24,
- Exclusion Criteria:
- • Individuals with pain and disability due to any shoulder pathology other than rotator cuff injury,
- • Individuals who cannot read or write Turkish,
- • Individuals with shoulder fractures, surgical interventions and other accompanying shoulder pathologies,
About Istanbul Medeniyet University
Istanbul Medeniyet University is a prominent academic institution based in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical standards and scientific rigor, Istanbul Medeniyet University collaborates with healthcare professionals and researchers to explore new therapeutic strategies and contribute to the global body of medical knowledge. Their commitment to fostering a research-driven environment facilitates the development of cutting-edge treatments and enhances patient care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
İstanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported